Search alternatives:
decrease tumor » increased tumor (Expand Search)
increased time » increased rate (Expand Search), increased age (Expand Search), increased il (Expand Search)
i resistance » _ resistance (Expand Search), high resistance (Expand Search), acid resistance (Expand Search)
decrease i » decrease _ (Expand Search), decreases _ (Expand Search), decreased _ (Expand Search)
Showing 21 - 40 results of 16,440 for search '(( decrease i resistance ) OR ( ((decrease tumor) OR (increased time)) resistance ))', query time: 0.88s Refine Results
  1. 21
    Supplementary Figure 1 from Reversal of Triple-Negative Breast Cancer EMT by miR-200c Decreases Tryptophan Catabolism and a Program of Immunosuppression

    Supplementary Figure 1 from Reversal of Triple-Negative Breast Cancer EMT by miR-200c Decreases Tryptophan Catabolism and a Program of Immunosuppression by Thomas J. Rogers (8041841)

    Published 2023
    Save to List
    Saved in:
  2. 22
    Cabozantinib treatment decreases microvessel density and increases hypoxic stress in SCNPC PDX models.

    Cabozantinib treatment decreases microvessel density and increases hypoxic stress in SCNPC PDX models. by Mark P. Labrecque (10011469)

    Published 2021
    Save to List
    Saved in:
  3. 23
    <i>CHGA</i> mRNA expression decreases with <i>CYB561</i> knockdown.

    <i>CHGA</i> mRNA expression decreases with <i>CYB561</i> knockdown. by Romie Angelo G. Azur (18547651)

    Published 2024
    Save to List
    Saved in:
  4. 24
    Overexpression of TMEM182 renders human OSCC cells resistance to miR-450a-decreased cell adhesion.

    Overexpression of TMEM182 renders human OSCC cells resistance to miR-450a-decreased cell adhesion. by En-Wei Hsing (154990)

    Published 2019
    Save to List
    Saved in:
  5. 25
    RAP and LRP-1 silencing by siRNA decreased the level and density of lysosome in MCF-7R cells.

    RAP and LRP-1 silencing by siRNA decreased the level and density of lysosome in MCF-7R cells. by Aubery Henry (17060668)

    Published 2023
    Save to List
    Saved in:
  6. 26
    Novel chromobox 2 inhibitory peptide decreases tumor progression

    Novel chromobox 2 inhibitory peptide decreases tumor progression by Lindsay W. Brubaker (15099942)

    Published 2023
    Save to List
    Saved in:
  7. 27
    Supplementary Table from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis

    Supplementary Table from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis by Shaina F. Bruce (15091273)

    Published 2023
    “…Supplementary Table from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis…”
    Save to List
    Saved in:
  8. 28
    Supplementary Figure from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis

    Supplementary Figure from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis by Shaina F. Bruce (15091273)

    Published 2023
    “…Supplementary Figure from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis…”
    Save to List
    Saved in:
  9. 29
    Supplementary Figure from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis

    Supplementary Figure from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis by Shaina F. Bruce (15091273)

    Published 2023
    “…Supplementary Figure from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis…”
    Save to List
    Saved in:
  10. 30
    Supplementary Figure from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis

    Supplementary Figure from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis by Shaina F. Bruce (15091273)

    Published 2023
    “…Supplementary Figure from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis…”
    Save to List
    Saved in:
  11. 31
    Supplementary Table from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis

    Supplementary Table from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis by Shaina F. Bruce (15091273)

    Published 2023
    “…Supplementary Table from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis…”
    Save to List
    Saved in:
  12. 32
    Supplementary Table from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis

    Supplementary Table from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis by Shaina F. Bruce (15091273)

    Published 2023
    “…Supplementary Table from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis…”
    Save to List
    Saved in:
  13. 33
    Supplementary Figure from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis

    Supplementary Figure from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis by Shaina F. Bruce (15091273)

    Published 2023
    “…Supplementary Figure from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis…”
    Save to List
    Saved in:
  14. 34
    Supplementary Figure from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis

    Supplementary Figure from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis by Shaina F. Bruce (15091273)

    Published 2023
    “…Supplementary Figure from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis…”
    Save to List
    Saved in:
  15. 35
    Supplementary Figure 3 from Reversal of Triple-Negative Breast Cancer EMT by miR-200c Decreases Tryptophan Catabolism and a Program of Immunosuppression

    Supplementary Figure 3 from Reversal of Triple-Negative Breast Cancer EMT by miR-200c Decreases Tryptophan Catabolism and a Program of Immunosuppression by Thomas J. Rogers (8041841)

    Published 2023
    Save to List
    Saved in:
  16. 36
    Supplementary Figure 2 from Reversal of Triple-Negative Breast Cancer EMT by miR-200c Decreases Tryptophan Catabolism and a Program of Immunosuppression

    Supplementary Figure 2 from Reversal of Triple-Negative Breast Cancer EMT by miR-200c Decreases Tryptophan Catabolism and a Program of Immunosuppression by Thomas J. Rogers (8041841)

    Published 2023
    Save to List
    Saved in:
  17. 37
    S4. IGF-1R inhibition did not decrease FoxO1 protein levels in MCF-7 cells. from IGF-1 Receptor Modulates FoxO1-Mediated Tamoxifen Response in Breast Cancer Cells

    S4. IGF-1R inhibition did not decrease FoxO1 protein levels in MCF-7 cells. from IGF-1 Receptor Modulates FoxO1-Mediated Tamoxifen Response in Breast Cancer Cells by Ali Vaziri-Gohar (13862857)

    Published 2023
    Save to List
    Saved in:
  18. 38
    <i>CYB561</i> knockdown decreased the survival, proliferation, and migration rates of PC-3 cells.

    <i>CYB561</i> knockdown decreased the survival, proliferation, and migration rates of PC-3 cells. by Romie Angelo G. Azur (18547651)

    Published 2024
    Save to List
    Saved in:
  19. 39
    Annual susceptible and resistant infections per 100,000 people per mechanism in 10 years of time.

    Annual susceptible and resistant infections per 100,000 people per mechanism in 10 years of time. by Noortje G. Godijk (9148318)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  20. 40
    DataSheet_1_Emodin Interferes With AKT1-Mediated DNA Damage and Decreases Resistance of Breast Cancer Cells to Doxorubicin.pdf

    DataSheet_1_Emodin Interferes With AKT1-Mediated DNA Damage and Decreases Resistance of Breast Cancer Cells to Doxorubicin.pdf by Bo Li (112195)

    Published 2021
    “…Here, we interrogate the role of Emodin, a chemical compound with tumor inhibitory properties, in the resistance of BC to Doxorubicin. …”
    Save to List
    Saved in:

Search Tools: